US Stock MarketDetailed Quotes

LYEL Lyell Immunopharma

Watchlist
  • 1.375
  • +0.015+1.10%
Trading Aug 13 15:50 ET
352.00MMarket Cap-1656P/E (TTM)

Lyell Immunopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lyell Immunopharma Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

--

Revenue(YoY)

13.00K

-51.85%
EPS(YoY)

-0.18

+30.77%
Analyst Rating

Buy

Aug 13, 2024

Lyell Immunopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q213.000K / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q413.000K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q213.000K / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q413.000K / 0.000--

Unlock Free Earnings Estimates

Lyell Immunopharma Earnings Reports

  • Lyell Immunopharma | 10-Q: Q2 2024 Earnings Report

    Aug 7 22:19 ET

  • Lyell Immunopharma | 10-Q: Q1 2024 Earnings Report

    May 6 08:09 ET

  • Lyell Immunopharma | 10-K: FY2023 Annual Report

    Feb 28 22:28 ET

  • Lyell Immunopharma | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 16:14 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 13, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg